New approach to particle therapy dosimetry
Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.
Dec 19, 2014
0
0
Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.
Dec 19, 2014
0
0
Tumor laterality (left-side vs. right-side) does not impact overall survival in breast cancer patients treated with breast-conserving surgery and adjuvant external beam radiation therapy, according to a study published in ...
Oct 20, 2014
0
0
Advances in medical imaging technology which could make proton beam therapy a viable treatment for many more cancer sufferers will be described on an international stage.
Sep 8, 2014
0
2
A recent study completed at the University of Eastern Finland provides new information on the limitations and potential new directions for the future development of transcranial ultrasound therapy.
Aug 4, 2014
0
0
A pioneering research project which aims to develop a more effective radiotherapy treatment for thousands of cancer sufferers will feature in a major public exhibition by The Royal Society.
Jul 1, 2014
0
0
Standard external beam radiation therapy (EBRT) provided a higher breast preservation rate than brachytherapy in women age 66 and older with invasive breast cancer, according to a study published in the February 1, 2014 print ...
Jan 29, 2014
0
0
A single dose of targeted radiotherapy delivered during or just after surgery could benefit some women undergoing treatment for early breast cancer, two new European studies suggest.
Nov 12, 2013
0
1
A secondary analysis of the historic RTOG 9202 prostate cancer trial examined results of men with intermediate-risk prostate cancer who had received long-term hormonal therapy after radiation therapy, and concluded that there ...
Sep 23, 2013
0
0
A shorter course of androgen suppression therapy prior to radiation therapy, when compared to a longer course of androgen suppression therapy, yields favorable outcomes and fewer adverse effects for intermediate-risk prostate ...
Sep 23, 2013
0
0
Adding the chemotherapy drug cisplatin to a treatment plan of radiation therapy (RT) and high-dose-rate brachytherapy (HDRB) for stage IIIB cervical cancer is beneficial, according to research presented today at the American ...
Sep 23, 2013
0
0